NEW YORK, Feb. 22 (GenomeWeb News) - Isis Pharmaceuticals and Rosetta Genomics plan to co-discover and -develop antisense drugs that regulate microRNAs for the treatment of hepatocellular carcinoma, the companies said today.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.
The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.
The New York Times writes that natural history museums are helping round out genetic studies with older specimens.
In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.